Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial
Michaela Diamant, Luc Van Gaal, Bruno Guerci, et al.
Journal of Diabetes Investigation
|
May 21, 2014
Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus
Linong Ji, Yukiko Onishi, Chul Woo Ahn, et al.
Diabetes Care
|
January 3, 2012
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study
David Russell-Jones, Robert M Cuddihy, Markolf Hanefeld, et al.
International Journal of Neonatal Screening
|
February 23, 2024
Stakeholder Views of the Proposed Introduction of Next Generation Sequencing into the Cystic Fibrosis Screening Protocol in England
Pru Holder, Corinna C Clark, Louise Moody, et al.
International Journal of Neonatal Screening
|
April 23, 2024
International Perspectives of Extended Genetic Sequencing When Used as Part of Newborn Screening to Identify Cystic Fibrosis
Corinna C A Clark, Pru Holder, Felicity K Boardman, et al.
Clinical Epidemiology
|
December 26, 2017
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
Jason C Simeone, Jay P Bae, Byron J Hoogwerf, et al.
Analytical Chemistry
|
July 19, 2016
Rapid Detection of Bacteria from Blood with Surface-Enhanced Raman Spectroscopy
Anna K Boardman, Winnie S Wong, W Ranjith Premasiri, et al.
European Journal of Medical Genetics
|
October 2, 2020
Which types of conditions should be included in reproductive genetic carrier screening? Views of parents of children with a genetic condition
Lauren A Thomas, Sharon Lewis, John Massie, et al.
Lancet (London, England)
|
November 13, 2012
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
John B Buse, Michael Nauck, Thomas Forst, et al.
Diabetologia
|
May 1, 2026
Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis
Lauren M Quinn, David Stanley, Francesca Milano, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial
Michaela Diamant, Luc Van Gaal, Bruno Guerci, et al.
Journal of Diabetes Investigation
|
May 21, 2014
Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus
Linong Ji, Yukiko Onishi, Chul Woo Ahn, et al.
Diabetes Care
|
January 3, 2012
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study
David Russell-Jones, Robert M Cuddihy, Markolf Hanefeld, et al.
International Journal of Neonatal Screening
|
February 23, 2024
Stakeholder Views of the Proposed Introduction of Next Generation Sequencing into the Cystic Fibrosis Screening Protocol in England
Pru Holder, Corinna C Clark, Louise Moody, et al.
International Journal of Neonatal Screening
|
April 23, 2024
International Perspectives of Extended Genetic Sequencing When Used as Part of Newborn Screening to Identify Cystic Fibrosis
Corinna C A Clark, Pru Holder, Felicity K Boardman, et al.
Clinical Epidemiology
|
December 26, 2017
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
Jason C Simeone, Jay P Bae, Byron J Hoogwerf, et al.
Analytical Chemistry
|
July 19, 2016
Rapid Detection of Bacteria from Blood with Surface-Enhanced Raman Spectroscopy
Anna K Boardman, Winnie S Wong, W Ranjith Premasiri, et al.
European Journal of Medical Genetics
|
October 2, 2020
Which types of conditions should be included in reproductive genetic carrier screening? Views of parents of children with a genetic condition
Lauren A Thomas, Sharon Lewis, John Massie, et al.
Lancet (London, England)
|
November 13, 2012
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
John B Buse, Michael Nauck, Thomas Forst, et al.
Diabetologia
|
May 1, 2026
Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis
Lauren M Quinn, David Stanley, Francesca Milano, et al.
Page
of 9